Translocation (3;21)(q26;q22) in therapy-related myelodysplasia following drugs targeting DNA-topoisomerase II combined with alkylating agnets, and in myeloproliferative disorders undergoing spontaneous leukemic transformation
- 31 August 1994
- journal article
- review article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 76 (1) , 50-55
- https://doi.org/10.1016/0165-4608(94)90071-x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- TRANSLOCATION (3;21)(q26–2;q22–1) FOUND IN A PATIENT WITH MYELODYSPLASTIC SYNDROME AND LONG‐TERM EXPOSURE TO ORGANIC SOLVENTSBritish Journal of Haematology, 1992
- Translocation (3;21) in a patient with secondary hematological malignancyCancer Genetics and Cytogenetics, 1990
- Apparent duplication of inv(3)(q21q26) in one of five cases with inv (3) in myelodysplastic syndromes and acute leukemiaAmerican Journal of Hematology, 1990
- Translocation t(3;21)(q26;q22) in acute myeloblastic leukemia secondary to polycythemia veraCancer Genetics and Cytogenetics, 1990
- Novel translocations in acute nonlymphocytic leukemiaCancer Genetics and Cytogenetics, 1990
- Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid LeukemiaNew England Journal of Medicine, 1989
- VARIANT (3:21) TRANSLOCATION AND MEGAKARYOCYTIC INVOLVEMENT IN BLASTIC CRISIS OF PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIABritish Journal of Haematology, 1989
- Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemiaAmerican Journal of Hematology, 1988
- Translocation (3;21) in Philadelphia chromosome—positive chronic myelogenous leukemia prior to the onset of blast crisisAmerican Journal of Hematology, 1988
- Philadelphia chromosome‐positive acute leukemia: Morphologic and clinical correlationsAmerican Journal of Hematology, 1987